<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> cells from 10 patients with Epstein-Barr virus-positive endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) have been examined for cell surface phenotype, both at the biopsy stage and during <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell line outgrowth in vitro, the cultures being followed for up to 150 passages </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> 10 cases, the biopsy cells showed coexpression of the common <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> antigen (CALLA) and of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-associated <z:chebi fb="0" ids="33563">glycolipid</z:chebi> antigen (BLA) with no accompanying expression of several "lymphoblastoid" cell surface markers defined by selected monoclonal antibodies </plain></SENT>
<SENT sid="2" pm="."><plain>During cell line establishment and in vitro passage, the individual <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines showed different degrees of progression toward a more "lymphoblastoid" cell surface phenotype, some even losing CALLA and BLA expression while retaining the chromosomal translocations indicative of their malignant origin </plain></SENT>
<SENT sid="3" pm="."><plain>This differential capacity for phenotypic progression in vitro explains much, if not <z:hpo ids='HP_0000001'>all</z:hpo>, of the <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> <z:mp ids='MP_0005384'>cell phenotype</z:mp> apparent from many previous studies with panels of long-established lines </plain></SENT>
<SENT sid="4" pm="."><plain>Such <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in vitro belies the true homogeneity of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0005384'>cell phenotype</z:mp> in vivo </plain></SENT>
</text></document>